Company profile
Abzu
Abzu is the best in class in silico disease understanding and drug design company.
- Industry
- Biotechnology Research
- Employees
- 18
- Headquarters
- Nordhavn, Capital Region
- Founded
- 2018
- LinkedIn followers
- 4,808
- Office locations
- 2
Abzu company summary
Abzu is a company in the Biotechnology Research industry, headquartered in Nordhavn, Capital Region, founded in 2018. On LinkedIn the company has around 18 employees and 4,808 followers. The company lists 2 office locations. Its listed specialties include RNA Therapeutics, RNA Tx, AI, artificial intelligence, explainable AI.
What technology does Abzu use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Abzu
Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D. Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.
Specialties
Where is Abzu located?
Abzu lists 2 office locations.
Compare companies similar to Abzu
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Abzu abzu.ai | Biotechnology Research | 18 | 2018 | Nordhavn, Capital Region |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Abzu
What does Abzu do?
Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D. Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.
How many employees does Abzu have?
Abzu has around 18 employees on LinkedIn.
Where is Abzu headquartered?
Abzu is headquartered in Nordhavn, Capital Region.
Where does Abzu have offices?
Abzu lists 2 office locations, including Nordhavn, Capital Region, DK; Barcelona, 08018, ES.
When was Abzu founded?
Abzu was founded in 2018.
Build a lead list from companies like Abzu
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.